GSN and myelodysplastic syndrome: GSN mRNA expression was significantly decreased in acute leukemia (t test, p < 0.0001), showing that decreased GSN transcription is not specific to MDS subgroups (Figure 4D) and suggesting that the increasing blasts between MDS-EB-2 and de novo acute leukemia might have different pathophysiology in terms of GSN expression.